OpenVSafe by OpenVAERS
Search V-safe

D6A-25529-48407

4 vaccinations 7 coded responses 32 check-ins 6 free-text entries 2 call cases
Sex
Female
Age at first dose
56-60
ZIP prefix
210 / MD
Registered
2021-02-20
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-02-20
    Registered in v-safe
  2. 2021-02-20
    Dose 1 — Moderna
  3. 2021-02-20
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  4. 2021-02-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  5. 2021-02-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-02-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Itching · None
    Adult check-in
  7. 2021-02-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-02-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-02-27
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-03-06
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-03-13
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-03-20
    Dose 2 — Moderna
  13. 2021-03-20
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  14. 2021-03-21
    Survey response — days 1–6 daily, dose 2
    MedDRA: Injection site swelling, Lymphadenopathy — Feeling: Fair · Site: Pain · Chills, Joint pains, Fatigue or tiredness
    Free text: Swollen gland near gluteal injection site
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-03-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  16. 2021-03-23
    Survey response — days 1–6 daily, dose 2
    MedDRA: Injection site erythema, Rash erythematous, Swelling — Feeling: Good · Site: Redness, Swelling
    Free text: Gluteal injection site was red, nearby gland on hip looked sunburned and was a bit puffy.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-03-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-03-25
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymph node pain — Feeling: Good · Site: Redness
    Free text: Lymph node near injection site still a bit sore. Not problematic.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-03-26
    Survey response — days 1–6 daily, dose 2
    MedDRA: Injection site reaction, Lymph node pain — Feeling: Good
    Free text: Gland near injection is tender
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  20. 2021-03-28
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  21. 2021-04-03
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-04-11
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-04-17
    Survey response — day 28, dose 2
    MedDRA: Acute febrile neutrophilic dermatosis, Increased tendency to bruise, Muscular weakness, Office visit, Pre-existing disease, Rash — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Severe rash, saw dermatologist and they suspect Sweet syndrome. Accompanied by mild muscle weakness and spontaneous bruising near joints. Awaiting biopsy of skin rash for diagnosis. I am a stage lung cancer patient on Tagrisso.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  24. 2021-04-17
    Report sent to call center — day 28, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  25. 2021-04-24
    Survey response — day 35, dose 2
    MedDRA: Acute febrile neutrophilic dermatosis, Arthralgia, Contusion, Neutrophil percentage increased, Peripheral swelling, Rash, Unevaluable event — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Symptoms: Rash, swelling and bruising in legs, joint pain. Suspected Sweet syndrome, diagnosis pending biopsy. C-reactive protein 1.94mg/dL (standard range <0.29mg/dL), neutrophil% 76.9% (std range 40-70). Rash began 4/13. Began prednisone today, exc respons · Healthcare visit (other): Prescription
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  26. 2021-04-24
    Report sent to call center — day 35, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  27. 2021-05-01
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  28. 2021-06-19
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  29. 2021-09-18
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  30. 2021-12-09
    Dose 3 — Pfizer-BioNTech
  31. 2022-03-20
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in
  32. 2022-04-01
  33. 2022-09-07
    Dose 4 — Pfizer-BioNTech
  34. 2022-09-21
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  35. 2022-09-28
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  36. 2022-10-05
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  37. 2022-10-12
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  38. 2022-10-19
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  39. 2022-12-07
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  40. 2023-03-08
    Survey response — 6 months, dose 4
    MedDRA: Hypoaesthesia — Feeling: Good
    MedDRA releases: 2024-11

Vaccinations

DoseDateManufacturerCo-administered
12021-02-20Moderna
22021-03-20Moderna
32021-12-09Pfizer-BioNTech No
42022-09-07Pfizer-BioNTech No

Call center

2 call center cases

2 unsuccessful

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 6 — days 1–6 daily, dose 2

2021-03-21

Systemic reaction (other): Swollen gland near gluteal injection site

2021-03-23

Systemic reaction (other): Gluteal injection site was red, nearby gland on hip looked sunburned and was a bit puffy.

2021-03-25

Systemic reaction (other): Lymph node near injection site still a bit sore. Not problematic.

2021-03-26

Systemic reaction (other): Gland near injection is tender

Release 7 — day 28, dose 2

2021-04-17

Symptoms: Severe rash, saw dermatologist and they suspect Sweet syndrome. Accompanied by mild muscle weakness and spontaneous bruising near joints. Awaiting biopsy of skin rash for diagnosis. I am a stage lung cancer patient on Tagrisso.

Release 7 — day 35, dose 2

2021-04-24

Symptoms: Rash, swelling and bruising in legs, joint pain. Suspected Sweet syndrome, diagnosis pending biopsy. C-reactive protein 1.94mg/dL (standard range <0.29mg/dL), neutrophil% 76.9% (std range 40-70). Rash began 4/13. Began prednisone today, exc respons cut off by CDC
Healthcare visit (other): Prescription

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOUnevaluable event ✓ ✓ ✓
SDAcute febrile neutrophilic dermatosis ✓ ✓ ✓
SDArthralgia ✓ ✓ ✓
SDContusion ✓ ✓ ✓
SDHypoaesthesia · · ✓
SDIncreased tendency to bruise ✓ ✓ ✓
SDMuscular weakness ✓ ✓ ✓
SDNeutrophil percentage increased ✓ ✓ ✓
SDOffice visit ✓ ✓ ✓
SDPeripheral swelling ✓ ✓ ✓
SDPre-existing disease ✓ ✓ ✓
SDRash ✓ ✓ ✓
SROInjection site erythema ✓ ✓ ✓
SROInjection site reaction ✓ ✓ ✓
SROInjection site swelling ✓ ✓ ✓
SROLymph node pain ✓ ✓ ✓
SROLymphadenopathy ✓ ✓ ✓
SRORash erythematous ✓ ✓ ✓
SROSwelling ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release